InferRead CT Lung
CH-RH

CE marked, FDA cleared, NMPA approved

High Generalization Ability and Rigorous Clinical Validation.

Efficient Analysis and High Sensitivity: effective for small nodules, improving efficiency and accuracy.

Intelligent Follow-up and Treatment Efficacy Evaluations: auto-analysis based on relevant priors to compare nodule development and improve treatment outcomes.

Intelligent Case Database: search for similar cases in the database, providing an intelligent reference for clinical decision making.

Structured Reporting: automatic report generation in accordance with professional guidelines.

InferRead CT Lung
CH-RH
With A.l., We Improve Human Life
1

Infervision North America

1900 Market Street, Fl 8th, Philadelphia, PA 19103

 

usa@infervision.com

Infervision Europe

Mainzer Straße 75, 65189 Wiesbaden, Germany

 

europe@infervision.com

Infervision China

18 / f, seat E, ocean international center, chaoyang district, Beijing

 

contact@infervision.com

Infervision APAC

601 Banchobiru, 3-4-5 Kudanminami, Chiyoda-ku, Tokyo, 102-0074

 

apac@infervision.ai

+81(0)3-6256-9810

Copyright © 2019   Infervision Medical Technology Co., Ltd.  All Rights Reserved.  京ICP备16032186号-1